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Tubulin, a ubiquitous protein of eukaryotic cytoskel-
eton, is a building block unit of microtubule. Although
several cellular processes are known to be mediated
through the tubulin-microtubule system, the participa-
tion of tubulin or microtubule in protein folding path-
way has not yet been reported. Here we show that goat
brain tubulin has some functions and features similar to
many known molecular chaperones. Substoichiometric
amounts of tubulin can suppress the non-thermal and
thermal aggregation of a number of unrelated proteins
such as insulin, equine liver alcohol dehydrogenase, and
soluble eye lens proteins containing b- and g-crystallins.
This chaperone-like activity of tubulin becomes more
pronounced as temperature increases. Aging of tubulin
solution at 37 °C also enhances its chaperone-like activ-
ity. Tubulin loses its chaperone-like activity upon re-
moval of its flexible hydrophilic C-terminal tail. These
results suggest that both electrostatic and hydrophobic
interactions are important in substrate binding by tu-
bulin and that the negatively charged C-terminal tails
play a crucial role for its chaperone-like activity.
Although it is the amino acid sequence of a protein that
determines its final three-dimensional structure of the func-
tional form, it is now well established that many proteins in
vivo as well as in vitro fail to fold correctly in the active form
without the aid from a class of proteins known as molecular
chaperones (1–4). During the process of their synthesis, trans-
location, and even during normal functioning in the cell (par-
ticularly under stress conditions) proteins are often subjected
to structural destabilization. Such conditions are likely to lead
to an increase in the propensity for proteins to aggregate,
leading to the ultimate death of the biopolymers. Chaperones
rescue these unstable conformers by binding to them and even-
tually through a concerted steps of events, often involving
appropriate co-factors and even other molecular chaperones,
guide the substrate proteins to the correct folded structure (2,
3).
Molecular chaperones occur ubiquitously in both prokaryotic
and eukaryotic cytosol, endoplasmic reticulum, mitochondria,
archaebacterial cytosol, and chloroplasts (2, 5). They comprise
several protein families, which are structurally unrelated.
These classes of proteins includes GroEL, BiP, GRP, TRAP,
TRiC, DnaJ gene products, and heat shock proteins such as
HSP40, HSP70, HSP90, etc. Molecular chaperones are now
known to perform diverse functions not only helping substrate
proteins to fold properly but also helping attain the correct fate
of the protein in vivo, be it proper oligomeric assembly, trans-
port to a particular subcellular compartment, or disposal of
unwanted protein by degradation (1, 5). Different chaperones
thus have different functions and they act sequentially (4).
However, irrespective of their functions, their action requires a
common step of binding the unstable non-native conformation
of the substrate, preventing the off-pathway reaction that leads
to protein aggregation.
The structural features of a protein that make it a chaperone
are poorly understood. However, a close observation of the
molecular chaperones known up to today reveals some inter-
esting facts. They have a domain containing a bundle of hydro-
phobic residues suitably located at the surface of the protein
enabling it to bind lipophilic substances such as 1-anilinon-
apthalene-8-sulfonic acid (ANS) or 4,49-dianilino-1,19-binaph-
thyl-5,5-disulfonic acid, dipotassium salt (bis-ANS) (6–8). Most
known chaperones, e.g. GroEL, DnaK, a-crystallin, etc., also
have a flexible hydrophilic tail, the absence of which leads to
loss of chaperone activity (9, 10). Because of these well sepa-
rated hydrophilic and hydrophobic domains, many chaperones
exist as a micelle-like large oligomeric form. GroEL exists as a
14-mer (9), and TriC is a ring complex having 8–9 subunits per
ring (11, 12). Proposed oligomeric structures of a-crystallin
that have chaperone-like activity (13) are based on micellar
architecture (14, 15). The list of new chaperones discovered is
increasing quite steadily.
Tubulin is a cytoskeleton protein that polymerizes to form
microtubules. Folding of tubulin in cytoskeleton is assisted by
the chaperone TCP-1 ring complex, also known as TRiC (16–
18). Tubulin in general seems to have some of the essential
characteristics of a chaperone protein such as surface hydro-
phobic pockets to bind lipophilic molecules (19, 20), a flexible
hydrophilic tail especially rich in acidic residues (21), and a
heterodimeric assembly of two subunits, a and b (Mr 50,000
each), which can further polymerize into microtubules. These
features prompted us to test whether tubulin possesses any
chaperone-like activity. The results presented in this commu-
nication reveal for the first time that tubulin has chaperone-
like properties as it can prevent the aggregation of a number of
proteins unrelated in structure or sequence.
EXPERIMENTAL PROCEDURES
Materials—PIPES,1 EGTA, GTP, insulin, subtilisin, phenylmethyl-
sulfonyl fluoride, dimethyl sulfoxide (Me2SO), dithiothreitol (DTT), and
alcohol dehydrogenase from equine liver were obtained from Sigma. All
other reagents were of analytical grade.
Purification of Tubulin—Tubulin was isolated from goat brains by
two cycles of GTP and temperature-dependent assembly and disassem-
bly in buffer containing 50 mM PIPES, 1 mM EGTA, and 0.5 mM MgCl2
(pH 7.0) followed by two further cycles in 1 M glutamate buffer (22). The
purified tubulin freed from microtubule-associated proteins was exten-
sively dialyzed against 10 mM phosphate buffer to remove any trace of
glutamate and stored in aliquots at 270 °C until use. Protein concen-
trations were determined by the method of Lowry et al. (23) using
bovine serum albumin as standard.
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Preparation of Lens Crystallin Fractions—Freshly excised bovine
eyes were obtained from a local slaughterhouse. The lenses were sur-
gically removed and homogenized in 20 mM Tris-HCl (pH 7.6) contain-
ing 0.1 M NaCl and 0.02% (w/v) NaN3. A water-soluble fraction was
obtained from the supernatant by centrifuging the homogenate at
27,000 3 g for 30 min at 4 °C. The supernatant was passed through a
100-kDa polysulfone membrane using an Amicon stirred cell. The fil-
trate thus collected was a-crystallin-depleted soluble lens protein, con-
taining a mixture of g-crystallin and low molecular weight b-crystallin
and other minor constituents of soluble lens proteins.
Assay of Protein Aggregation—Insulin dissolved in a minimum vol-
ume of 0.02 M NaOH was diluted to the required concentration (0.3
mg/ml) in 100 mM phosphate buffer (pH 7.0). The reduction of insulin
was initiated by adding 20 ml of 1 M DTT to 1 ml of the sample in the
spectrophotometric cuvette, and the extent of aggregation of the insulin
B chain was measured as a function of time at 25 °C by monitoring the
apparent absorbance (scattering) at 360 nm in a Shimadzu UV-160
spectrophotometer. Thermally induced aggregation of alcohol dehydro-
genase and soluble lens protein fractions were also measured in the
same spectrophotometer using a thermostatic cell holder assembly
maintained at constant temperature through a circulating water bath.
Protein solution and buffer were mixed in the cuvette at room temper-
ature and then placed in the thermostatic cell holder, and apparent
absorbance was measured as function of time. For calculating the molar
ratio of protein:tubulin resulting in nearly complete protection of ag-
gregation, the molecular masses of tubulin, insulin, alcohol dehydro-
genase, and a-crystallin-depleted soluble lens protein were taken as
100, 5.7, 80, and 60 kDa, respectively, of which the last one is an
average value for the protein mixtures and not unambiguous (13).
Preparation of asbs—Digestion of tubulin with subtilisin was per-
formed at 30 °C in 100 mM phosphate buffer with 1 mM GTP. Subtilisin
was taken in the ratio enzyme:protein 5 1:100 (w/w). The reaction was
terminated by the addition of 1% by volume of 1% (w/v) phenylmethyl-
sulfonyl fluoride in Me2SO.
RESULTS AND DISCUSSION
Insulin and alcohol dehydrogenase were used as substrates
to study chaperone-like activity of many proteins including
a-crystallin and HSP proteins. Aggregation of both insulin and
alcohol dehydrogenase is suppressed when incubated in the
presence of a-crystallin or HSP proteins (24, 25). Reduction of
the disulfide bonds between the A and B chains of insulin with
dithiothreitol rapidly leads to the aggregation of B chains. To
investigate the function of goat brain tubulin, the aggregation
of insulin (0.3 mg/ml) in 100 mM phosphate buffer (pH 7.0) was
monitored at 25 °C in the absence and presence of varied
amounts of goat brain tubulin. As shown in Fig. 1A, curve 1,
insulin lost its native conformation upon cleavage of its disul-
fide bond at 25 °C. Denaturation was accompanied by aggrega-
tion. Bovine serum albumin had virtually no effect on the
aggregation of insulin (data not shown). When the same exper-
iment was performed in the presence of goat brain tubulin,
aggregation was suppressed. At an insulin to tubulin weight
ratio of 1:1, aggregation was significantly reduced (Fig. 1A,
curve 2). At an insulin to tubulin weight ratio of 1:8, the
aggregation was almost completely suppressed (Fig. 1A, curve
3). There was no evidence of any aggregation at a 1:10 weight
ratio (data not shown). This complete prevention of aggregation
corresponds to a stoichiometric ratio of 1:0.6 for insulin:tubu-
lin. Thermal aggregation of alcohol dehydrogenase was carried
out at 37 °C. Tubulin showed a pronounced effect on the pre-
vention of aggregation of alcohol dehydrogenase, and at the
alcohol dehydrogenase to tubulin weight ratio of 1:1 corre-
sponding to a stoichiometric ratio of 1:0.8, 80% suppression of
aggregation occurred (Fig. 1B, curve 3).
It is known that a-crystallin acts as a molecular chaperone
on a native mixture of lens proteins (13). Thus the absence of
a-crystallin from the total soluble protein fraction of lens ho-
mogenate (consisting of g-crystallin and low molecular weight
b-crystallin fractions and all other low molecular weight solu-
ble components) caused thermal aggregation at 60 °C (13).
Addition of a-crystallin to the soluble lens protein fraction
prevented the thermal aggregation. We have tested the effect of
tubulin on the thermal aggregation of soluble lens proteins
devoid of a-crystallin at 60 °C (Fig. 2). Tubulin showed a pro-
nounced effect on the suppression of aggregation of soluble lens
protein fraction even at a weight ratio of lens protein:tubulin as
low as 1:0.2 (Fig. 2). Complete suppression of aggregation re-
quired the lens proteins:tubulin weight ratio of 1:0.5, corre-
sponding to a stoichiometric ratio of 1:0.3.
Chaperone-like activity of many proteins become more pro-
nounced at a higher temperature. The heat shock protein,
HSP90, and a-crystallin bind more effectively to unfolded sub-
strate proteins in the thermally modified form (7, 26–28). We
have studied the prevention of thermal aggregation of insulin
at 25 °C by tubulin, which was first incubated at 50 °C and
then brought back to 25 °C. At an insulin:tubulin ratio of 1:1
(w/w) the prevention of aggregation by control insulin is 50% at
25 °C (Fig. 3A, curve 2). However, when tubulin preincubated
at 50 °C was used in the same weight ratio, almost complete
prevention of aggregation occurs (Fig. 3A, curve 3). We have
also tested the effectiveness of tubulin preincubated alone at
37 °C for different periods of times (aged or thermally modified
tubulin) to prevent the aggregation of alcohol dehydrogenase.
Results of such an experiment are shown in Fig. 3B. Experi-
ments were carried out at an insulin to tubulin weight ratio of
1:1 (molar ratio, ;1:0.06) at 25 °C. Tubulins used were native
and 1, 2, 3, and 4 h aged at 37 °C. Although native tubulin
inhibits 50% aggregation of insulin at 25 °C, prevention is
much more with aged tubulin (Fig. 3B). Thermal treatment of
tubulin and its aging at 37 °C are known to expose hydrophobic
sites leading to enhanced binding of hydrophobic probes (19,
20). It is suggested that molecular chaperones suppress aggre-
gation by providing appropriately placed hydrophobic surfaces
to the denaturing protein substrates. Our observation of en-
hanced activity of thermally modified tubulin (Fig. 3B, inset)
also indicates a direct correlation of chaperone-like activity
with exposure of surface hydrophobic groups.
One of the characteristics of many known chaperones is the
existence of a flexible tail region. GroEL is known to have
FIG. 1. Aggregation of insulin and alcohol dehydrogenase in
the absence and presence of brain tubulin. A, aggregation of in-
sulin (0.3 mg) B-chains was initiated using DTT in 100 mM phosphate
buffer (pH 7.0) at 25 °C in a volume of 1 ml with: curve 1, only insulin;
curve 2, plus 0.3 mg of tubulin; curve 3, plus 2.4 mg of tubulin. B,
aggregation of alcohol dehydrogenase (0.4 mg/ml) in 50 mM phosphate
buffer (pH 7.0) at 37 °C in a volume of 1.0 ml with the following
conditions: curve 1, only alcohol dehydrogenase; curve 2, plus 0.2 mg of
tubulin; curve 3, plus 0.4 mg of tubulin; curve 4, 2 mg of tubulin.
Aggregation was monitored by measuring absorbance at 360 nm.
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flexible N- and C-terminal residues, which protrude in the
central cavity and because of their flexibility are not resolved in
the crystal structure (9). It was shown by NMR spectroscopy
that a-crystallin and HSP25 have unstructured, flexible, and
solvent-exposed C-terminal extensions (25). It was hypothe-
sized that the polar and unstructured flexible C-terminal end
plays a critical role in substrate-chaperone interactions and
also functions as a solubilizer. In fact, mutation in the C-
terminal end, deletion of 17 residues from the C-terminal end
(10), or enzymatic truncation of the C terminus caused a
marked reduction in chaperone-like activity of a-crystallin (29,
30). C termini of both a- and b-subunits of tubulin are rich in
acidic residues, especially glutamic acid (21). Because of the
highest negative charge density, both termini are exposed to
solvents, susceptible to proteolysis, and thought to be highly
flexible (31, 32). Subtilisin can cleave both C termini when
incubated with tubulin at 37 °C. Thus, the obvious question is
does the removal of C termini of tubulin change its chaperone-
like activity? The results of such an experiment are shown in
Fig. 4. Tubulin lost its chaperone-like activity when the C
termini of both subunits (asbs) are removed using subtilisin
(Fig. 4). It is interesting to note that complete loss of chaper-
one-like activity needs removal of the C terminus from both the
subunits. When the digestion is partial (Fig. 4, curve 3), tubulin
retains some chaperone-like activity.
The functional significance of this finding is not clear at
present. In eukaryotic cytosol, folding of proteins including
tubulin and actin is mediated by the chaperonin TRiC (16–18).
TRiC is known to be present in all eukaryotic cytosol (2).
Although TRiC has a double cylindrical architecture very sim-
ilar to that of GroEL, it is known to mediate the folding of only
a very limited subset of proteins including tubulin and actin.
This is in sharp contrast to the generally wide selectivity of
GroEL (2). The relative abundance of TRiC in many cell types
is quite low (5). There is also no evidence to date for the other
abundant chaperones in the eukaryotic cytosol such as HSP90
to play any significant role in protein folding (2). It is therefore
an open question as to how the majority of the proteins in the
eukaryotic cytosol fold. Our finding of the chaperone-like activ-
ity of tubulin may have some role in the formation or mainte-
nance of native conformation of cytosolic proteins. The answer
to the question whether tubulin itself helps the proteins to fold
or just holds the polypeptide temporarily before being taken up
by TRiC or some other hitherto unknown chaperone to guide
the substrates through folding awaits further study.
In summary, we have identified tubulin as having a chaper-
one-like function. Like GroEL, HSPs, small HSPs, and other
members of the molecular chaperone family, tubulin is able to
prevent the irreversible aggregation of proteins under heat
shock as well as other conditions. Like other chaperones, its
activity increases with a rise of temperature. Its activity is
sensitive to the deletion of its flexible hydrophilic tail, a feature
known also for other chaperones.
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